[Quantity of Treg cells and Th17 cells in spleen of primary immune thrombocytopenic purpura patients]

Zhonghua Xue Ye Xue Za Zhi. 2017 Mar 14;38(3):227-230. doi: 10.3760/cma.j.issn.0253-2727.2017.03.010.
[Article in Chinese]

Abstract

Objective: To observe the quantity of Treg cells and Th17 cells in spleen of adult primary immune thrombocytopenic purpura (ITP) patients. Methods: 43 ITP cases with splenectomy treatment were enrolled from December 2008 to June 2016 at Union Hospital of Fujian Medical University, including 20 males and 23 females with a median age of 36 (18-76) years. The controls were thirty patients who underwent splenectomy because of pancreatic diseases or splenic impairment, including 21 males and 9 females with a median age of 47 (21-69) years. The quantity and ratio of Treg cells and Th17 cells were examined by immunohistochemistry between ITP patients and controls. Results: ①The quantity of Treg cells in ITP were less than controls[ (11.3±4.7) /mm(2) vs (59.0±15.0) /mm(2), t=-22.894, P<0.001], but Th17 cells were more than controls[ (235.2±69.4) /mm(2) vs (181.1±23.7) /mm(2), t=13.768, P<0.001]. So the ratio of Treg/Th17 in ITP was lower than controls (0.048±0.027 vs 0.328±0.086, t=19.522, P<0.001) . ② The quantity of Treg cells in cases without response after splenectomy were less than cases with response[ (9.5±5.0) /mm(2) vs (11.6±4.7) /mm(2), t=2.723, P=0.010], and there is no statistical differences between the two groups about the quantity of Th17 cells and the ratio of Treg/Th17 cells[ (232.3±80.8) /mm(2) vs (239.6±66.9) /mm(2), t=1.108, P=0.277; 0.040±0.024 vs 0.053±0.027, t=0.540, P=0.592]. Conclusions: There is a significant difference about the quantity of Treg cells and Th17 cells in spleen between ITP patients and healthy controls, and they are relevant to the response after splenectomy.

目的:观察成人原发免疫性血小板减少症(ITP)患者脾脏组织中调节性T细胞(Treg细胞)和Th17细胞的变化。方法: 2008年12月1日至2016年6月30日期间在福建医科大学附属协和医院接受脾切除术治疗的43例ITP患者纳入研究,男20例,女23例,中位年龄36(18~76)岁。以30例因胰腺疾病或脾外伤接受脾切除术的患者作为对照组,男21例,女9例,中位年龄47(21~69)岁。运用免疫组化技术对脾脏组织中Treg细胞和Th17细胞数量进行观察,计算Treg细胞/Th17细胞比值,分析ITP组与对照组以及脾切除有效与无效ITP患者脾脏组织中Treg、Th17细胞数量及Treg/Th17细胞比值差异。结果: ①ITP组脾脏组织中Treg细胞少于对照组[(11.3±4.7)个/mm(2)对(59.0±15.0)个/mm(2),t=-22.894,P<0.001],Th17细胞多于对照组[(235.2±69.4)个/mm(2)对(181.1±23.7)个/mm(2),t=13.768,P<0.001],Treg/Th17细胞比值低于对照组(0.048±0.027对0.328±0.086,t=19.522,P<0.001)。②脾切除术无效ITP患者脾脏组织中Treg细胞少于有效患者[(9.5±5.0)个/mm(2)对(11.6±4.7)个/mm(2),t=2.723,P=0.010],Th17细胞计数、Treg/Th17细胞比值差异无统计学意义[(232.3±80.8)个/mm(2)对(239.6±66.9)个/mm(2),t=1.108,P=0.277;0.040±0.024对0.053±0.027,t=0.540,P=0.592]。结论:成人ITP患者脾脏组织中Treg、Th17细胞数量有显著改变,可能与脾切除术疗效有一定关联。.

Keywords: Splenectomy; T-Lymphocytes, regulatory; Th17 cells; Thrombocytopenia.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Purpura, Thrombocytopenic, Idiopathic
  • Spleen
  • Splenectomy
  • T-Lymphocytes, Regulatory*
  • Th17 Cells*
  • Young Adult

Grants and funding

基金项目:国家临床重点专科建设及福建省临床重点专科建设(2012-966);福建省卫计委青年项目(2014-1-42)